Record title

Real-world patient characteristics associated with survival of 2 years or more after radium-223 treatment for metastatic castration-resistant prostate cancer (EPIX study)

Record identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9184267

https://collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9184267

Real-world patient characteristics associated with survival of 2 years or more after radium-223 treatment for metastatic castration-resistant prostate cancer (EPIX study)

About this item

Full title

Real-world patient characteristics associated with survival of 2 years or more after radium-223 treatment for metastatic castration-resistant prostate cancer (EPIX study)

Publisher

England: Nature Publishing Group

Journal title

Prostate cancer and prostatic diseases, 2022, Vol.25 (2), p.306-313

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9184267

Language

English

Formats

Publication information

Publisher

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9184267

Permalink

https://collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9184267

Other Identifiers

ISSN

E-ISSN

DOI

How to access this item